Tech Company Financing Transactions

Sirion Therapeutics Funding Round

Sirion Therapeutics secured a $45 million Series B financing round on 4/9/2007. Investors included Aisling Capital, Advent International and Atlas Venture.

Transaction Overview

Announced On
Transaction Type
Venture Equity
Series B
Proceeds Purpose
Barry Butler, President and CEO of Sirion Therapeutics, said that the proceeds from this raisewill be used to advance the company's pipeline of products.

Company Information

Company Status
Out of Business
Mailing Address
3110 Cherry Palm Drive 340
Tampa, FL 33619
Email Address
Sirion Therapeutics is an ophthalmic-focused company dedicated to the development and commercialization of innovative eye products to address unmet clinician and patient needs.
Sirion Therapeutics LinkedIn Company Profile
Social Media
Sirion Therapeutics Company Twitter Account
Company News
Sirion Therapeutics News
Sirion Therapeutics on Facebook
Sirion Therapeutics on YouTube

Management Team

Email & Social
Chief Executive Officer
Barry Butler
  Barry Butler LinkedIn Profile  Barry Butler Twitter Account  Barry Butler News  Barry Butler on Facebook
Chief Financial Officer
Todd Creech
  Todd Creech LinkedIn Profile  Todd Creech Twitter Account  Todd Creech News  Todd Creech on Facebook
Chief Medical Officer
Roger Vogel
  Roger Vogel LinkedIn Profile  Roger Vogel Twitter Account  Roger Vogel News  Roger Vogel on Facebook
Chief Scientific Officer
Nathan Mata
  Nathan Mata LinkedIn Profile  Nathan Mata Twitter Account  Nathan Mata News  Nathan Mata on Facebook
Yvonne Gallimore
  Yvonne Gallimore LinkedIn Profile  Yvonne Gallimore Twitter Account  Yvonne Gallimore News  Yvonne Gallimore on Facebook
Vice President
Susan Benton
  Susan Benton LinkedIn Profile  Susan Benton Twitter Account  Susan Benton News  Susan Benton on Facebook
Vice President
Christine Miller
  Christine Miller LinkedIn Profile  Christine Miller Twitter Account  Christine Miller News  Christine Miller on Facebook
Vice President
Erin Parsons
  Erin Parsons LinkedIn Profile  Erin Parsons Twitter Account  Erin Parsons News  Erin Parsons on Facebook
Vice President
Susan Vaisey
  Susan Vaisey LinkedIn Profile  Susan Vaisey Twitter Account  Susan Vaisey News  Susan Vaisey on Facebook
VP - Bus. Development
Philippe Boulangeat
  Philippe Boulangeat LinkedIn Profile  Philippe Boulangeat Twitter Account  Philippe Boulangeat News  Philippe Boulangeat on Facebook
VP - Manufacturing
William Stringer
  William Stringer LinkedIn Profile  William Stringer Twitter Account  William Stringer News  William Stringer on Facebook
VP - Marketing
Susan Benton
  Susan Benton LinkedIn Profile  Susan Benton Twitter Account  Susan Benton News  Susan Benton on Facebook
VP - Marketing
Dave Cobb
  Dave Cobb LinkedIn Profile  Dave Cobb Twitter Account  Dave Cobb News  Dave Cobb on Facebook
VP - Operations
Lisa Butler
  Lisa Butler LinkedIn Profile  Lisa Butler Twitter Account  Lisa Butler News  Lisa Butler on Facebook
VP - Operations
Todd Lehman
  Todd Lehman LinkedIn Profile  Todd Lehman Twitter Account  Todd Lehman News  Todd Lehman on Facebook
VP - Operations
Kimberly Mcleod
  Kimberly Mcleod LinkedIn Profile  Kimberly Mcleod Twitter Account  Kimberly Mcleod News  Kimberly Mcleod on Facebook
VP - Regulatory Affairs
Debra Gessneer
  Debra Gessneer LinkedIn Profile  Debra Gessneer Twitter Account  Debra Gessneer News  Debra Gessneer on Facebook



Browse more venture capital transactions:

Prev: 4/9/2007: Kalido venture capital transaction
Next: 4/9/2007: H2O Audio venture capital transaction


Share this article


Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary